1. Academic Validation
  2. Pharmacological properties of BN82451: a novel multitargeting neuroprotective agent

Pharmacological properties of BN82451: a novel multitargeting neuroprotective agent

  • CNS Drug Rev. 2007 Fall;13(3):317-32. doi: 10.1111/j.1527-3458.2007.00018.x.
Pierre Etienne Chabrier 1 Michel Auguet
Affiliations

Affiliation

  • 1 Ipsen; Institut Henri Beaufour, Les Ulis, France. pierreet.chabrier@ipsen.com
Abstract

BN82451 belongs to a new family of small molecules designated as multitargeting or hybrid molecules. BN82451 is orally active, has good central nervous system penetration, and elicits potent neuronal protection and antiinflammatory properties. Neuronal protection is due to Na+ channel blockade, antioxidant properties, and mitochondria-protecting activity, whereas inhibition of cyclooxygenases is mostly responsible for its antiinflammatory activity. BN82451 has been shown to exert a potent neuroprotective effect in various in vitro and in vivo animal models. BN82451 was found to exert a significant protection in experimental animal models mimicking aspects of cerebral ischemia, Parkinson disease, Huntington disease, and more particularly amyotrophic lateral sclerosis. Collectively, its pharmacological properties designate BN82451 as a promising neuroprotective agent.

Figures
Products
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验,部分功能也使用 Cookies 帮助我们更好地理解您的需求,为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问,请阅读我们的《隐私声明》